-
3601
-
3602
Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease
Published 2024-03-01“…Meilan Xian,1,2,* Jiaoyuan Xu,1,3,* Yamei Zheng,4 Lei Zhang,4 Jie Zhao,4 Jie Chen,1 Siguang Li,1 Lingsang Lin,1 Yi Zhong,4 Zehua Yang,4 Tian Xie,4 Linhui Huang,4 Yipeng Ding1,4 1Department of General Practice, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, Hainan, 570311, People’s Republic of China; 2Department of General Diseases, Hainan Chengmei Hospital, Haikou, Hainan, 570300, People’s Republic of China; 3Department of General Clinic, Longbo Health Hospital, Lingao County, Hainan, 571800, People’s Republic of China; 4Department of Pulmonary and Critical Care Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yipeng Ding; Linhui Huang, Department of General Practice, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, No. 19, Xiuhua Road, Xiuying District, Haikou, Hainan, 570311, People’s Republic of China, Email ypding@yeah.net; rochelle-11@163.comBackground: Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder in pulmonology. Chuanbeimu (CBM) is a traditional Chinese medicinal herb for treating COPD and has been widely utilized in clinical practice. …”
Get full text
Article -
3603
-
3604
-
3605
-
3606
Leptin favors Th17/Treg cell subsets imbalance associated with allergic asthma severity
Published 2022-06-01Get full text
Article -
3607
-
3608
-
3609
-
3610
The effects of a ‘COVID Nurse Assistant’ application on patient satisfaction in COVID isolation rooms
Published 2023-02-01Get full text
Article -
3611
Characterization of Severe Uncontrolled Asthma in Japan: Analysis of Baseline Data from the PROSPECT Study
Published 2023-06-01“…Toshiyuki Koya,1 Kazuhisa Asai,2 Takashi Iwanaga,3 Yu Hara,4 Mai Takahashi,5 Naoyuki Makita,5 Nobuya Hayashi,6 Naoki Tashiro,5 Yuji Tohda7,8 1Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; 2Department of Respiratory Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; 3Center for General Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osakasayama, Japan; 4Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan; 5Medical Department, AstraZeneca KK, Osaka, Japan; 6R&D, AstraZeneca KK, Osaka, Japan; 7Department of Respiratory Medicine and Allergology, Kindai University Faculty of Medicine, Osakasayama, Japan; 8Kinki Hokuriku Airway disease Conference (KiHAC) Group, Osakasayama, JapanCorrespondence: Toshiyuki Koya, Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-ku, Niigata, 951-8510, Japan, Tel +81 25-368-9325, Fax +81 25-368-9326, Email tkoya@med.niigata-u.ac.jpPurpose: Treatment patterns and patient characteristics are not well elucidated among Japanese patients with severe uncontrolled asthma who currently have various treatment options, including biologics. …”
Get full text
Article -
3612
-
3613
-
3614
-
3615
Basophil Activation Test Utility as a Diagnostic Tool in LTP Allergy
Published 2022-04-01Get full text
Article -
3616
-
3617
-
3618
Exploring the association between ultra-processed foods and COPD: a case-control study
Published 2024-03-01Get full text
Article -
3619
-
3620
Assessing SARS-CoV-2 Vertical Transmission and Neonatal Complications
Published 2021-11-01Get full text
Article